ZWS Stock Forecast & Price Target

Zurn Elkay Water Solns is favorably positioned because it delivered a clear 1Q26 operating beat, with adjusted EBITDA ahead by 8%, organic sales up 11% versus guidance of 7%-8%, and EPS rising 34% year over year to $0.41, showing that demand and profitability are both accelerating across nearly all product categories. The business also entered 2Q26 with guidance above consensus, calling for 8%-9% organic growth and 27%-27.5% EBITDA margins, while incremental EBITDA margins of 41% and free cash flow conversion of 61% in 1Q26 underscore strong operating leverage and cash generation. Its outlook is further supported by a resilient, specification-driven and sustainability-focused portfolio, 0.5x net leverage, broad end-market strength in institutional and commercial channels, and management’s ability to offset tariff pressure through supply-chain de-risking and productivity improvements without needing additional price increases.

Zurn Elkay Water Solns is exposed to a weak fundamental setup because roughly 80% of sales come from nonresidential and institutional end markets, with about 39% of total sales tied to healthcare and education, making results highly dependent on construction activity and deferred institutional budgets that can easily slow demand. Although the company reported 11% organic growth and 160 bps of EBITDA margin expansion, much of that performance was helped by about 5% price realization, favorable weather-driven break/fix activity, and mix benefits, which may not be durable enough to offset the risk from softer residential demand and slowing nonresidential spending. The business also faces margin pressure from commodity volatility and supply disruptions, execution risk across a broad SKU portfolio, potential governance constraints from the Horne family’s ~68% voting power, and the possibility that it fails to scale Smart & Connected products or capture expected synergies and outgrowth.